Dr. Nandish Jeevangi, Consultant Medical Oncology, HCG Cancer Centre, Kalaburagi
Lung cancer is the third riskiest form of cancer. This cancer has affected millions of people around the world. Lung cancer is caused due to abnormal cell division in the lungs. The mutated or damaged cells, when divide themselves abnormally, form masses or tumors of tissue which hinder the functioning of the lungs. Lung cancer often begins in the airway, bronchi or bronchioles or in the small air sacs, alveoli. Lung cancer consists of two major types: Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC). Each of these have their own subtypes and the treatment options differ for both.
Non-Small Cell Lung Cancer (NSCLC):
Non-Small Cell Lung Cancer constitutes for about 85% of the total cases of lung cancer reported. This form of lung cancer consists of several subtypes. Adenocarcinoma often originates in the outer regions of the lung and is the most common type of NSCLC. Smoking has been linked to the development of squamous cell carcinoma, which often starts in the bigger airways. A less frequent variant of lung cancer called the large cell carcinoma can appear anywhere in the lungs.
Diagnosis:
Through biopsies, molecular testing, and imaging studies we can diagnose NSCLC. Cancer staging establishes the extent of the disease’s spread and directs medical decisions. The selection of treatment depends on the stage, which ranges from I (localized) to IV (advanced).
Treatment Options for NSCLC:
Immunotherapy: This approach has shown promising results in extending survival as it stimulates the immune system directly and destroys the cancer results. The results have been noticed in a few NSCLC patients.
Small Cell Lung Cancer (SCLC):
Small Cell Lung Cancer is more aggressive and difficult to treat unlike NSCLC. This form of lung cancer begins as a small tumor in the lungs and spreads rapidly to other parts of the body during its initial stages of development.
Specific subtypes of SCLC include small cell carcinoma also known as “oat cell carcinoma” and combined small cell carcinoma.
This form of lung cancer has two distinct stages namely, limited, and extensive. While the limited stage SCLC is confined to one lung and nearby lymph nodes, the extensive stage SCLC spreads to other parts of the lung and distant sites.
Diagnosis:
Similar to NSCLC, SCLC can be diagnosed through biopsies, molecular testing, and imaging studies and also through series of physical examinations, CT scans, X-rays and medical history evaluation.
Treatment Options for SCLC:
Prevention:
Any type of lung cancer can be prevented by adopting lifestyle changes, environmental awareness, regular health checkups and being aware of one’s own body.
Each subtype of lung cancer requires a specific strategy to treatment because it is a complicated disease with several subtypes. The likelihood of a positive outcome is significantly increased by early diagnosis, precise staging, and tailored treatment approaches.
By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…
Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…
New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…
National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…
Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…
New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…